We gratefully acknowledge the team at Bioduro for their considerable efforts on this project and in particular Mr. Dan Contoit to whom we dedicate this article upon his untimely passing. He is greatly missed by all who knew him.
We also acknowledge discussions with Dr. Mary Lingerfelt, Dr. Ana Puhl Rubio at Collaborations Pharmaceuticals, Inc. as well as Dr. Gauri Rao and Mr. John Diep at UNC for earlier discussions. Dr. Mindy Davis is gratefully acknowledged for assistance with the NIAID virus screening capabilities.